Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 171 - 180 of 202

Selected Filters:
1 November 2022

Missed Opportunities for Healthcare Providers to Discuss HIV Preexposure Prophylaxis with People who Inject Drugs

This article from the International Journal of Drug Policy identifies missed opportunities for healthcare providers to discuss PrEP with people who inject drugs.

Service Delivery

External Link
1 November 2022

The Importance of Assessing and Addressing Mental Health Barriers to PrEP Use during Pregnancy and Postpartum in Sub-Saharan Africa: State of the science and research priorities

This article from the Journal of the International AIDS Society highlights key research priorities that can support PrEP adherence and persistence during pregnancy and the post-partum period by addressing mental health barriers.

Research, Service Delivery

External Link
1 November 2022

Stigma in the Health Clinic and Implications for PrEP Access and Use by Adolescent Girls and Young Women: Conflicting perspectives in South Africa

This article from BMC Public Health presents the results of a mixed methods study exploring stigma toward adolescent girls and young women (AGYW) seeking PrEP services, from the perspective of both clinic staff (clinical and nonclinical) and AGYW who seek services at clinic sites in Tshwane province, South Africa.

Service Delivery

External Link
20 October 2022

Results of 90 Day Tenofovir plus Levonorgestrel Vaginal Ring Trial: The CONRAD 138 study

This article from PLOS One presents the results of a randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics, and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women to prevent both pregnancy and HIV.

Research

External Link
19 October 2022

From Policy to Practice: Uptake of PrEP among adolescent girls and young women in PEPFAR-supported countries, 2017–2020

This article from the journal AIDS describes the uptake of PrEP amongst adolescent girls and young women in PEPFAR countries.

Monitoring & Evaluation

External Link
6 October 2022

Socio-behavioral Correlates of Pre-exposure Prophylaxis Use and Correct Adherence in Men who have Sex with Men in West Africa

This article from BMC Public Health reports on results from the CohMSM study in Burkina Faso, Côte d’Ivoire, Mali, and Togo relating to PrEP adherence amongst gay and bisexual men who have sex with men.

Research

External Link
4 October 2022

Acceptability of Injectable Pre-exposure Prophylaxis among People who Inject Drugs in Three Urban U.S. Settings

This article from BMC Infectious Diseases examines acceptability of injectable PrEP amongst people who inject drugs in the US.

Research

External Link
4 October 2022

Continued Attendance in a PrEP Program despite Low Adherence and Non-protective Drug Levels among Adolescent Girls and Young Women in Kenya: Results from a prospective cohort study

This article from PLOS Medicine measures adherence to oral PrEP amongst adolescent girls and young women in Kenya in the DREAMS program while exploring reasons behind adherence.

Monitoring & Evaluation

External Link
4 October 2022

Long-Acting Injectable Cabotegravir for HIV Prevention: What do we know and need to know about the risks and consequences of cabotegravir resistance?

This article from The Science of Prevention summarizes what is known about cabotegravir (CAB) pharmacokinetics, activity, and emergence of resistance from in vitro, macaque and clinical studies, and evaluates the risk of resistance from CAB for PrEP with on-time injections and after CAB for PrEP discontinuation.

Monitoring & Evaluation, Research, Testing

External Link
16 September 2022

Engaging HIV-Prevention Ambassadors to Promote Oral PrEP among Adolescent Girls and Young Women: Results of a Zimbabwe field test

This article from the African Journal of AIDS Research describes the results of a field test of the HIV Prevention Ambassador Training Package for Adolescent Girls and Young Women, a toolkit designed to improve skills, knowledge, and attitudes about oral PrEP among peer ambassadors.

Community/Advocacy, Demand Creation/Marketing, Research

External Link